Thayyezhuth Devika, Venkataram Rajesh, Bhat Vadisha Srinivas, Aroor Rajeshwary
K S Hegde Medical Academy, Mangalore, India.
Heliyon. 2021 Oct 29;7(11):e08270. doi: 10.1016/j.heliyon.2021.e08270. eCollection 2021 Nov.
Allergic rhinitis (AR) is a common IgE -mediated inflammatory condition characterised by sneezing, nasal congestion, itching and rhinorrhoea. Nasal allergy is a strong risk factor for the onset of asthma in adults. Bronchial hyper-responsiveness (BHR) is a distinct feature of pathophysiology in asthma. Spirometric parameters like Forced Expiratory Volume in first second [FEV1] and Forced Expiratory Flow [FEF ] are known to be impaired in patients with allergic rhinitis. We studied these parameters in subjects of AR who have never experienced any chest symptoms. It is well known that, subjects with allergic rhinitis are at greater risk of developing overt bronchial asthma in future.
All patients presented with symptoms of allergic rhinitis without history of bronchial asthma were included. Patients those who were clinically diagnosed with allergic rhinitis were evaluated with absolute eosinophilic count, serum IgE and Spirometric assessment. In spirometry, post bronchodilator FEV1 reversibility and post bronchodilator FEF values were used to assess lower airway abnormalities.
Among 61 subjects, 32 were males and 29 were females. The maximum numbers [28] of patients were in 21-35 age group. Absolute eosinophil count was elevated in 38% of patients. 33% of patients showed elevated IgE values above 1000. 43% of patients showed FEV1 reversibility which is a sign of Bronchial hyperreactivity. 5% of patients showed impaired post bronchodilator FEF which indicates presence of small airway disease. There was significant correlation between FEV1 reversibility and elevated IgE.
Impaired spirometric parameters indicate coexistence of bronchial impairment and hence predisposition to progression from allergic rhinitis alone to overt asthma in future. Thus careful evaluation of lower airway has to be done to rule out coexisting subclinical asthma.
变应性鼻炎(AR)是一种常见的IgE介导的炎症性疾病,其特征为打喷嚏、鼻塞、鼻痒和流涕。鼻过敏是成人哮喘发病的一个重要危险因素。支气管高反应性(BHR)是哮喘病理生理学的一个显著特征。已知变应性鼻炎患者的肺功能参数如第一秒用力呼气量[FEV1]和用力呼气流量[FEF]会受损。我们在从未有过任何胸部症状的AR患者中研究了这些参数。众所周知,变应性鼻炎患者未来发生明显支气管哮喘的风险更高。
纳入所有有变应性鼻炎症状但无支气管哮喘病史的患者。对临床诊断为变应性鼻炎的患者进行绝对嗜酸性粒细胞计数、血清IgE和肺功能评估。在肺功能检查中,使用支气管扩张剂后FEV1可逆性和支气管扩张剂后FEF值来评估下气道异常。
61名受试者中,男性32名,女性29名。患者数量最多的[28名]在21 - 35岁年龄组。38%的患者绝对嗜酸性粒细胞计数升高。33%的患者IgE值高于1000。43%的患者表现出FEV1可逆性,这是支气管高反应性的一个标志。5%的患者支气管扩张剂后FEF受损,这表明存在小气道疾病。FEV1可逆性与IgE升高之间存在显著相关性。
肺功能参数受损表明支气管功能受损并存,因此未来有变应性鼻炎单独进展为明显哮喘的易感性。因此,必须仔细评估下气道以排除并存的亚临床哮喘。